COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

1 . A compound of Formula (I):

or a pharmaceutically acceptable salt thereof, or an N-oxide thereof,

wherein:

Z is selected from the group consisting of a bond, CR 1 , C(R 3 ) 2 , N, and NR 2 ;

each of Y 1 , Y 2 , and Y 3 is independently selected from the group consisting of O, S, CR 1 , C(R 3 ) 2 , N, and NR 2 ;

Y 4 is C;

X 1 is selected from the group consisting of O, S, N, NR 2 , and CR 1 ;

X 2 is CR 5 ;

each is independently a single bond or a double bond, provided that the five-membered ring comprising Y 4 , X 1 , and X 2 is heteroaryl;

W is selected from the group consisting of:

(i) C(═O);

(ii) C(═S);

(iii) S(O) 1-2 ;

(iv) C(═NR d );

(v) C(═NH);

(vi) C(═C—NO 2 );

(vii) S(O)N(R d ); and

(viii) S(O)NH;

Q-A is defined according to (A) or (B) below:

(A)

Q is NH or N(C 1-6 alkyl) wherein the C 1-6 alkyl is optionally substituted with 1-2 independently selected R a , and

A is:

(i) —(Y A1 ) n —Y A2 , wherein:

n is 0 or 1;

Y A1 is C 1-6 alkylene, which is optionally substituted with from 1-6 R a ; and

Y A2 is:

(a) C 3-20 cycloalkyl, which is optionally substituted with from 1-4 R b ,

(b) C 6-20 aryl, which is optionally substituted with from 1-4 R c ;

(c) heteroaryl including from 5-20 ring atoms, wherein from 1-4 ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R d ), O, and S, and wherein one or more of the heteroaryl ring carbon atoms are optionally substituted with from 1-4 independently selected R c , or

(d) heterocyclyl including from 3-16 ring atoms, wherein from 1-3 ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R b ), N(R d ), and O, and wherein one or more of the heterocyclyl ring carbon atoms are optionally substituted with from 1-4 independently selected R b ,

OR

(ii) —Z 1 —Z 2 —Z 3 , wherein:

Z 1 is C 1-3 alkylene, which is optionally substituted with from 1-4 R a ;

Z 2 is —N(H)—, —N(R d )—, —O—, or —S—; and

Z 3 is C 2-7 alkyl, which is optionally substituted with from 1-4 R a ;

OR

(iii) C 1-10 alkyl, which is optionally substituted with from 1-6 independently selected R a , or

(B)

Q and A, taken together, form:

 wherein denotes point of attachment to W; and

E is a ring including from 3-16 ring atoms, wherein aside from the nitrogen atom present, from 0-3 additional ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R d ), and O, and wherein one or more of the heterocyclyl ring carbon atoms are optionally substituted with from 1-4 independently selected R b ,

each occurrence of R 1 is independently selected from the group consisting of H; halo; cyano; C 1-6 alkyl optionally substituted with 1-2 R a ; C 2-6 alkenyl; C 2-6 alkynyl; C 1-4 haloalkyl; C 1-4 alkoxy; C 1-4 haloalkoxy; —(C 0-3 alkylene)-C 3-6 cycloalkyl optionally substituted with from 1-4 independently selected R g ; —(C 0-3 alkylene)-C 6-10 aryl optionally substituted with from 1-4 independently selected R g ; —(C 0-3 alkylene)-5-10 membered heteroaryl, wherein from 1-3 ring atoms of the heteroaryl are heteroatoms each independently selected from the group consisting of N, NH, NR d , O, and S, wherein the heteroaryl is optionally substituted with from 1-4 independently selected R g ; —(C 0-3 alkylene)-5-10 membered heterocyclyl, wherein from 1-3 ring atoms of the heterocyclyl are heteroatoms each independently selected from the group consisting of N, NH, NR d , O, and S, wherein the heterocyclyl is optionally substituted with 1-4 independently selected R g ; —S(O) 1-2 (C 1-4 alkyl); —NR e R f ; —OH; oxo; —S(O) 1-2 (NR′R″); —C 1-4 thioalkoxy; —NO 2 ; —C(═O)(C 1-4 alkyl); —C(═O)O(C 1-4 alkyl); —C(═O)OH; and —C(═O)N(R′)(R″);

each occurrence of R 2 is independently selected from the group consisting of:

(i) C 1-6 alkyl, which is optionally substituted with from 1-2 independently selected R a ;

(ii) C 3-6 cycloalkyl;

(iii) heterocyclyl including from 3-10 ring atoms, wherein from 1-3 ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R d ), and O;

(iv) —C(O)(C 1-4 alkyl);

(v) —C(O)O(C 1-4 alkyl);

(vi) —CON(R′)(R″);

(vii) —S(O) 1-2 (NR′R″);

(viii) —S(O) 1-2 (C 1-4 alkyl);

(ix) —OH;

(x) C 1-4 alkoxy; and

(xi) H;

each occurrence of R 3 is independently selected from the group consisting of H, C 1-6 alkyl optionally substituted with from 1-6 independently selected R a ; C 1-4 haloalkyl; —OH; —F; —Cl; —Br; —NR e R f ; C 1-4 alkoxy; C 1-4 haloalkoxy; —C(═O)(C 1-4 alkyl); —C(═O)O(C 1-4 alkyl); —C(═O)OH; —C(═O)N(R′)(R″); —S(O) 1-2 (NR′R″); —S(O) 1-2 (C 1-4 alkyl); cyano; and C 3-6 cycloalkyl optionally substituted with from 1-4 independently selected C 1-4 alkyl; or two R 3 on the same carbon combine to form an oxo;

R 4 is selected from the group consisting of H and C 1-6 alkyl;

R 5 is selected from the group consisting of H, halo, C 1-4 alkoxy, OH, oxo, and C 1-6 alkyl;

each occurrence of R a is independently selected from the group consisting of: —OH; —F; —Cl; —Br; —NR e R f ; C 1-4 alkoxy; C 1-4 haloalkoxy; —C(═O)O(C 1-4 alkyl); —C(═O)(C 1-4 alkyl); —C(═O)OH; —CON(R′)(R″); —S(O) 1-2 (NR′R″); —S(O) 1-2 (C 1-4 alkyl); cyano, and C 3-6 cycloalkyl optionally substituted with from 1-4 independently selected C 1-4 alkyl;

each occurrence of R b is independently selected from the group consisting of: C 1-10 alkyl optionally substituted with from 1-6 independently selected R a ; C 1-4 haloalkyl; —OH; oxo; —F; —Cl; —Br; —NR e R f ; C 1-4 alkoxy; C 1-4 haloalkoxy; —C(═O)(C 1-4 alkyl); —C(═O)O(C 1-4 alkyl); —C(═O)OH; —C(═O)N(R′)(R″); —S(O) 1-2 (NR′R″); —S(O) 1-2 (C 1-4 alkyl); cyano; (C 0-3 alkylene)-C 6-10 aryl optionally substituted with 1-4 independently selected C 1-4 alkyl; and (C 0-3 alkylene)-C 3-6 cycloalkyl optionally substituted with from 1-4 independently selected C 1-4 alkyl;

each occurrence of R c is independently selected from the group consisting of:

(i) halo;

(ii) cyano;

(iii) C 1-10 alkyl which is optionally substituted with from 1-6 independently selected R a ;

(iv) C 2-6 alkenyl;

(v) C 2-6 alkynyl;

(vi) C 1-4 haloalkyl;

(vii) C 1-4 alkoxy;

(viii) C 1-4 haloalkoxy;

(ix) —(C 0-3 alkylene)-C 3-6 cycloalkyl optionally substituted with from 1-4 independently selected C 1-4 alkyl;

(x) —(C 0-3 alkylene)-heterocyclyl, wherein the heterocyclyl includes from 3-16 ring atoms, wherein from 1-3 ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R d ), and O;

(xi) —S(O) 1-2 (C 1-4 alkyl);

(xii) —NR e R f ;

(xiii) —OH;

(xiv) —S(O) 1-2 (NR′R″);

(xv) —C 1-4 thioalkoxy;

(xvi) —NO 2 ;

(xvii) —C(═O)(C 1-4 alkyl);

(xviii) —C(═O)O(C 1-4 alkyl);

(xix) —C(═O)OH;

(xx) —C(═O)N(R′)(R″);

(xxi) —(C 0-3 alkylene)-C 6-10 aryl optionally substituted with from 1-4 independently selected C 1-4 alkyl; and

(xxii) —(C 0-3 alkylene)-5-10 membered heteroaryl, wherein from 1-3 ring atoms of the heteroaryl are heteroatoms each independently selected from the group consisting of N, NH, NR d , O, and S, wherein the heteroaryl is optionally substituted with from 1-4 independently selected C 1-4 alkyl;

R d is selected from the group consisting of: C 1-6 alkyl; C 3-6 cycloalkyl; —C(O)(C 1-4 alkyl); —C(O)O(C 1-4 alkyl); —CON(R′)(R″); —S(O) 1-2 (NR′R″); —S(O) 1-2 (C 1-4 alkyl); —CN; —OH; and C 1-4 alkoxy;

each occurrence of R e and R f is independently selected from the group consisting of: H; C 1-6 alkyl; C 1-6 haloalkyl; C 3-6 cycloalkyl; —C(O)(C 1-4 alkyl); —C(O)O(C 1-4 alkyl); —CON(R′)(R″); —S(O) 1-2 (NR′R″); —S(O) 1-2 (C 1-4 alkyl); —OH; and C 1-4 alkoxy; or R e and R f together with the nitrogen atom to which each is attached forms a ring including from 3-8 ring atoms, wherein the ring includes: (a) from 1-7 ring carbon atoms, each of which is substituted with from 1-2 substituents independently selected from the group consisting of H and C 1-3 alkyl; and (b) from 0-3 ring heteroatoms (in addition to the nitrogen atom attached to R e and R f ), which are each independently selected from the group consisting of N(R d ), O, and S;

each occurrence of R g is independently selected from the group consisting of: halo; cyano; C 1-6 alkyl optionally substituted with from 1-2 independently selected R a ; C 1-4 haloalkyl; C 1-6 alkoxy optionally substituted with 1-2 independently selected R a ; C 1-4 haloalkoxy; S(O) 1-2 (C 1-4 alkyl); —NR e R f ; —OH; oxo; —S(O) 1-2 (NR′R″); —C 1-4 thioalkoxy; —NO 2 ; —C(═O)(C 1-4 alkyl); —C(═O)O(C 1-4 alkyl); —C(═O)OH; and —C(═O)N(R′)(R″); and

each occurrence of R′ and R″ is independently selected from the group consisting of: H and C 1-4 alkyl; or R′ and R″ together with the nitrogen atom to which each is attached forms a ring including from 3-8 ring atoms, wherein the ring includes: (a) from 1-7 ring carbon atoms, each of which is substituted with from 1-2 substituents independently selected from the group consisting of: H and C 1-3 alkyl; and (b) from 0-3 ring heteroatoms (in addition to the nitrogen atom attached to R′ and R″), which are each independently selected from the group consisting of N(R d ), O, and S,

provided that one or more of a), b), and c) apply:

a) one or more of Z, Y 1 , Y 2 , Y 3 , and Y 4 in the ring below

 is an independently selected heteroatom;

b) the ring that includes Z, Y 1 , Y 2 , Y 3 , and Y 4 is partially unsaturated; OR

c) Z is a bond;

further provided that when Q-A is defined according to (A); A is C 6 aryl mono-substituted with C 4 alkyl such as n-butyl at the para position; and the ring that includes Z, Y 1 , Y 2 , Y 3 , and Y 4 is aromatic, then the ring that includes Z, Y 1 , Y 2 , Y 3 , and Y 4 must be substituted with one or more R 1 that is other than hydrogen; and

and further provided with the proviso that the compound is not selected from the group consisting of:

2 . (canceled)

3 . The compound of claim 1 , wherein the ring that includes Z, Y 1 , Y 2 , Y 3 , and Y 4 :

is aromatic.

4 . The compound of claim 1 , wherein Z is other than a bond.

5 . The compound of claim 1 , wherein from 1-2 of Z, Y 1 , Y 2 , Y 3 , and Y 4 is independently N.

6 . The compound of claim 1 , wherein the ring that includes Z, Y 1 , Y 2 , Y 3 , and Y 4 is selected from the group consisting of:

wherein each denotes points of attachment to the ring comprising X 1 and X 2 , and wherein the bottom denotes point of attachment to X 1 .

7 . The compound of claim 1 , wherein the ring comprising Z, Y 1 , Y 2 , Y 3 , and Y 4 is selected from the group consisting of:

wherein each denotes points of attachment to the ring comprising X 1 and X 2 , and wherein the bottom denotes point of attachment to X 1 .

8 . The compound of claim 1 , wherein Z is a bond.

9 - 12 . (canceled)

13 . The compound of claim 1 , wherein the ring that includes Z, Y 1 , Y 2 , Y 3 , and Y 4 is partially unsaturated.

14 - 19 . (canceled)

20 . The compound of claim 1 , wherein X 1 is NH.

21 . The compound of claim 1 , wherein the compound has a formula selected from the group consisting of:

22 . The compound of claim 1 , wherein the compound has a formula selected from the group consisting of:

23 - 44 . (canceled)

45 . The compound of claim 1 , wherein W is C(═O).

46 . The compound of claim 1 , wherein Q and A are defined according to (A).

47 . The compound of claim 46 , wherein A is —(Y A1 ) n —Y A2 .

48 . The compound of claim 47 , wherein n is 0.

49 . The compound of n m claim 47 , wherein n is 1.

50 . The compound of claim 49 , wherein Y A1 is C 1-3 alkylene, such as CH 2 or CH 2 CH 2 .

51 . The compound of claim 47 , wherein Y A2 is C 6-20 aryl, which is optionally substituted with from 1-4 R c .

52 - 55 . (canceled)

56 . The compound of claim 47 , wherein Y A2 is heteroaryl including from 5-20 ring atoms, wherein from 1-4 ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R d ), O, and S, and wherein one or more of the heteroaryl ring carbon atoms are optionally substituted with from 1-4 independently selected R c .

57 - 70 . (canceled)

71 . The compound of claim 47 , wherein Y A2 is C 3-20 cycloalkyl, which is optionally substituted with from 1-4 R b .

72 . The compound of claim 47 , wherein Y A2 is heterocyclyl including from 3-12 ring atoms, wherein from 1-3 ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R d ), and O, and wherein one or more of the heterocyclyl ring carbon atoms are optionally substituted with from 1-4 independently selected R b .

73 - 79 . (canceled)

80 . The compound of claim 1 , wherein Q and A are defined according to (B).

81 - 130 . (canceled)

131 . A compound of Formula (I):

or a pharmaceutically acceptable salt thereof, or an N-oxide thereof,

wherein:

one or more of Z, Y 1 , Y 2 , Y 3 , and Y 4 in the ring below

 is an independently selected heteroatom;

Z is selected from the group consisting of CR 1 and N;

each of Y 1 , Y 2 , and Y 3 is independently selected from the group consisting of CR 1 and N;

provided that one or more of Z, Y 1 , Y 2 , and Y 3 is an independently selected CR 1 ;

Y 4 is C;

X is NH;

X 2 is CH;

each is independently a single bond or a double bond, provided that the five-membered ring comprising Y 4 , X 1 , and X 2 is heteroaryl; and

the ring that includes Z, Y 1 , Y 2 , Y 3 , and Y 4 is aromatic;

W is selected from the group consisting of:

(i) C(═O);

(ii) C(═S);

(iv) C(═NR d ); and

(v) C(═NH);

Q-A is defined according to (A) or (B) below:

(A)

Q is NH or N(C 1-6 alkyl) wherein the C 1-6 alkyl is optionally substituted with 1-2 independently selected R a , and

A is:

(i) —(Y A1 ) n —Y A2 , wherein:

n is 0 or 1;

Y A1 is C 1-6 alkylene, which is optionally substituted with from 1-6 R a ; and

Y A2 is:

(a) C 3-20 cycloalkyl, which is optionally substituted with from 1-4 R b ,

(b) C 6-20 aryl, which is optionally substituted with from 1-4 R c ;

(c) heteroaryl including from 5-20 ring atoms, wherein from 1-4 ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R d ), O, and S, and wherein one or more of the heteroaryl ring carbon atoms are optionally substituted with from 1-4 independently selected R c , or

(d) heterocyclyl including from 3-16 ring atoms, wherein from 1-3 ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R b ), N(R d ), and O, and wherein one or more of the heterocyclyl ring carbon atoms are optionally substituted with from 1-4 independently selected R b ,

OR

(ii) —Z 1 —Z 2 —Z 3 , wherein:

Z 1 is C 1-3 alkylene, which is optionally substituted with from 1-4 R a ;

Z 2 is —N(H)—, —N(R d )—, —O—, or —S—; and

Z 3 is C 2-7 alkyl, which is optionally substituted with from 1-4 R a ;

OR

(iii) C 1-10 alkyl, which is optionally substituted with from 1-6 independently selected R a ,

OR

(B)

Q and A, taken together, form:

 wherein denotes point of attachment to W; and

E is a ring including from 3-16 ring atoms, wherein aside from the nitrogen atom present, from 0-3 additional ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R d ), and O, and wherein one or more of the heterocyclyl ring carbon atoms are optionally substituted with from 1-4 independently selected R b ,

each occurrence of R 1 is independently selected from the group consisting of H; halo; cyano; C 1-6 alkyl optionally substituted with 1-2 R a ; C 2-6 alkenyl; C 2-6 alkynyl; C 1-4 haloalkyl; C 1-4 alkoxy; C 1-4 haloalkoxy; —(C 0-3 alkylene)-C 3-6 cycloalkyl optionally substituted with from 1-4 independently selected R g ; —(C 0-3 alkylene)-C 6-10 aryl optionally substituted with from 1-4 independently selected R g ; —(C 0-3 alkylene)-5-10 membered heteroaryl, wherein from 1-3 ring atoms of the heteroaryl are heteroatoms each independently selected from the group consisting of N, NH, NR d , O, and S, wherein the heteroaryl is optionally substituted with from 1-4 independently selected R g ; —(C 0-3 alkylene)-5-10 membered heterocyclyl, wherein from 1-3 ring atoms of the heterocyclyl are heteroatoms each independently selected from the group consisting of N, NH, NR d , O, and S, wherein the heterocyclyl is optionally substituted with 1-4 independently selected R g ; —S(O) 1-2 (C 1-4 alkyl); —NR e R f ; —OH; oxo; —S(O) 1-2 (NR′R″); —C 1-4 thioalkoxy; —NO 2 ; —C(═O)(C 1-4 alkyl); —C(═O)O(C 1-4 alkyl); —C(═O)OH; and —C(═O)N(R′)(R″);

each occurrence of R a is independently selected from the group consisting of: —OH; —F; —Cl; —Br; —NR e R f ; C 1-4 alkoxy; C 1-4 haloalkoxy; —C(═O)O(C 1-4 alkyl); —C(═O)(C 1-4 alkyl); —C(═O)OH; —CON(R′)(R″); —S(O) 1-2 (NR′R″); —S(O) 1-2 (C 1-4 alkyl); cyano; and C 3-6 cycloalkyl optionally substituted with from 1-4 independently selected C 1-4 alkyl;

each occurrence of R b is independently selected from the group consisting of: C 1-10 alkyl optionally substituted with from 1-6 independently selected R a ; C 1-4 haloalkyl; —OH; oxo; —F; —Cl; —Br; —NR e R f ; C 1-4 alkoxy; C 1-4 haloalkoxy; —C(═O)(C 1-4 alkyl); —C(═O)O(C 1-4 alkyl); —C(═O)OH; —C(═O)N(R′)(R″); —S(O) 1-2 (NR′R″); —S(O) 1-2 (C 1-4 alkyl); cyano; (C 0-3 alkylene)-C 6-10 aryl optionally substituted with 1-4 independently selected C 1-4 alkyl; and (C 0-3 alkylene)-C 3-6 cycloalkyl optionally substituted with from 1-4 independently selected C 1-4 alkyl;

each occurrence of R c is independently selected from the group consisting of:

(i) halo;

(ii) cyano;

(iii) C 1-10 alkyl which is optionally substituted with from 1-6 independently selected R a ;

(iv) C 2-6 alkenyl;

(v) C 2-6 alkynyl;

(vi) C 1-4 haloalkyl;

(vii) C 1-4 alkoxy;

(viii) C 1-4 haloalkoxy;

(ix) —(C 0-3 alkylene)-C 3-6 cycloalkyl optionally substituted with from 1-4 independently selected C 1-4 alkyl;

(x) —(C 0-3 alkylene)-heterocyclyl, wherein the heterocyclyl includes from 3-16 ring atoms, wherein from 1-3 ring atoms are heteroatoms, each independently selected from the group consisting of N, N(H), N(R d ), and O;

(xi) —S(O) 1-2 (C 1-4 alkyl);

(xii) —NR e R f ;

(xiii) —OH;

(xiv) —S(O) 1-2 (NR′R″);

(xv) —C 1-4 thioalkoxy;

(xvi) —NO 2 ;

(xvii) —C(═O)(C 1-4 alkyl);

(xviii) —C(═O)O(C 1-4 alkyl);

(xix) —C(═O)OH;

(xx) —C(═O)N(R′)(R″); and

(xxi) —(C 0-3 alkylene)-C 6-10 aryl optionally substituted with from 1-4 independently selected C 1-4 alkyl; and

(xxii) —(C 0-3 alkylene)-5-10 membered heteroaryl, wherein from 1-3 ring atoms of the heteroaryl are heteroatoms each independently selected from the group consisting of N, NH, NR d , O, and S, wherein the heteroaryl is optionally substituted with from 1-4 independently selected C 1-4 alkyl;

R d is selected from the group consisting of: C 1-6 alkyl; C 3-6 cycloalkyl; —C(O)(C 1-4 alkyl); —C(O)O(C 1-4 alkyl); —CON(R′)(R″); —S(O) 1-2 (NR′R″); —S(O) 1-2 (C 1-4 alkyl); —OH; —CN; and C 1-4 alkoxy;

each occurrence of R e and R f is independently selected from the group consisting of: H; C 1-6 alkyl; C 1-6 haloalkyl; C 3-6 cycloalkyl; —C(O)(C 1-4 alkyl); —C(O)O(C 1-4 alkyl); —CON(R′)(R″); —S(O) 1-2 (NR′R″); —S(O) 1-2 (C 1-4 alkyl); —OH; and C 1-4 alkoxy; or R e and R f together with the nitrogen atom to which each is attached forms a ring including from 3-8 ring atoms, wherein the ring includes: (a) from 1-7 ring carbon atoms, each of which is substituted with from 1-2 substituents independently selected from H and C 1-3 alkyl; and (b) from 0-3 ring heteroatoms (in addition to the nitrogen atom attached to R e and R f ), which are each independently selected from the group consisting of N(R d ), O, and S;

each occurrence of R g is independently selected from the group consisting of: halo; cyano; C 1-6 alkyl optionally substituted with from 1-2 independently selected R a ; C 1-4 haloalkyl; C 1-6 alkoxy optionally substituted with 1-2 independently selected R a ; C 1-4 haloalkoxy; S(O) 1-2 (C 1-4 alkyl); —NR e R f ; —OH; oxo; —S(O) 1-2 (NR′R″); —C 1-4 thioalkoxy; —NO 2 ; —C(═O)(C 1-4 alkyl); —C(═O)O(C 1-4 alkyl); —C(═O)OH; and —C(═O)N(R′)(R″);

and

each occurrence of R′ and R″ is independently selected from the group consisting of: H and C 1-4 alkyl; or R′ and R″ together with the nitrogen atom to which each is attached forms a ring including from 3-8 ring atoms, wherein the ring includes: (a) from 1-7 ring carbon atoms, each of which is substituted with from 1-2 substituents independently selected from H and C 1-3 alkyl; and (b) from 0-3 ring heteroatoms (in addition to the nitrogen atom attached to R′ and R″), which are each independently selected from the group consisting of N(R d ), O, and S;

provided that when Q-A is defined according to (A); A is C 6 aryl mono-substituted with a C 4 alkyl such as n-butyl at the para position, then the ring that includes Z, Y 1 , Y 2 , Y 3 , and Y 4 must be substituted with one or more R 1 that is other than hydrogen; and

further provided with the proviso that the compound is other than one or more of the following:

132 - 254 . (canceled)

255 . A compound selected from the group consisting of the following compounds.

Compound #

Structure

100

102

103

104

106

107

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

127

129

130

131

132

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

159

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

179

180

181

182

183

183b

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

236

237

238

239

240

241

242

243

244

245

246

247

248

249

250

251

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

269

270

271

272

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

290

291

292

293

294

295

296

297

298

299

300

301

302

303

304

305

306

307

308

309

310

311

312

313

314

315

316

317

318

319

320

321

322

323

324

325

326

327

328

329

330

331

332

333

334

335

336

337

338

339

340

341

342

343

344

345

346

347

348

349

350

351

352

353

354

355

356

357

358

359

360

361

362

363

364

365

366

367

368

369

370

371

372

373

374

375

376

377

378

379

380

381

382

383

384

385

386

387

388

;

or a pharmaceutically acceptable salt thereof.

256 . A pharmaceutical composition comprising a compound of claim 1 and one or more pharmaceutically acceptable excipients.

257 . A method for inhibiting STING activity, the method comprising contacting STING with a compound as claimed in claim 1 .

258 - 273 . (canceled)

274 . A method of treating cancer, comprising administering to a subject in need of such treatment an effective amount of a compound as claimed in claim 1 , or a pharmaceutical composition thereof.

275 - 281 . (canceled)

282 . A method of inducing an immune response in a subject in need thereof, the method comprising administering to the subject an effective amount of a compound as claimed in claim 1 , or a pharmaceutical composition thereof.

283 - 290 . (canceled)

291 . A method of treatment of a disease in which increased (e.g., excessive) STING signaling contributes to the pathology and/or symptoms and/or progression of the disease, comprising administering to a subject in need of such treatment an effective amount of a compound as claimed in claim 1 , or a pharmaceutical composition thereof.

292 - 301 . (canceled)

302 . A method of treatment of a disease, disorder, or condition associated with STING, comprising administering to a subject in need of such treatment an effective amount of a compound as claimed in claim 1 , or a pharmaceutical composition thereof.

303 - 310 . (canceled)